Literature DB >> 16837497

Successful treatment of refractory adult onset Still's disease with rituximab.

K Ahmadi-Simab, P Lamprecht, C Jankowiak, W L Gross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16837497      PMCID： PMC1798247          DOI： 10.1136/ard.2005.047621

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  Lymphadenopathy in adult-onset Still's disease mimicking peripheral T-cell lymphoma.

Authors:  Mehmet Soy; Melek Ergin; Semra Paydas
Journal:  Clin Rheumatol       Date:  2003-12-20       Impact factor: 2.980

2.  Clinical manifestations, disease course, and complications of adult-onset Still's disease in Taiwan.

Authors:  Der-Yuan Chen; Joung-Liang Lan; Tsu-Yi Hsieh; Yi-Hsing Chen
Journal:  J Formos Med Assoc       Date:  2004-11       Impact factor: 3.282

3.  Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?

Authors:  E H J G Aarntzen; P L C M van Riel; P Barrera
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

4.  Rapid responses to anakinra in patients with refractory adult-onset Still's disease.

Authors:  Avril A Fitzgerald; Sharon A Leclercq; Alexander Yan; Joanne E Homik; Charles A Dinarello
Journal:  Arthritis Rheum       Date:  2005-06

5.  A case of adult-onset Still's disease complicated by non-Hodgkin's lymphoma.

Authors:  H Sono; K Matsuo; H Miyazato; M Sakaguchi; M Matsuda; K Hamada; Y Tatsumi; Y Maeda; M Funauchi; A Kanamaru
Journal:  Lupus       Date:  2000       Impact factor: 2.911

6.  Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.

Authors:  Der-Yuan Chen; Joung-Liang Lan; Fang-Ju Lin; Tsu-Yi Hsieh
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

7.  Septicemia with Staphylococcus aureus, beta-hemolytic streptococci group B and G, and Escherichia coli in a patient with rheumatoid arthritis treated with a recombinant human interleukin 1 receptor antagonist (Anakinra).

Authors:  Carl Turesson; Kristian Riesbeck
Journal:  J Rheumatol       Date:  2004-09       Impact factor: 4.666

8.  Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy.

Authors:  Y K Jeon; J H Paik; S-S Park; S O Park; Y A Kim; J E Kim; Y W Song; C W Kim
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

9.  Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Authors:  Jonathan C W Edwards; Leszek Szczepanski; Jacek Szechinski; Anna Filipowicz-Sosnowska; Paul Emery; David R Close; Randall M Stevens; Tim Shaw
Journal:  N Engl J Med       Date:  2004-06-17       Impact factor: 91.245
  9 in total
  9 in total

Review 1.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

2.  [Adult onset Still's disease].

Authors:  B Manger
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

Review 3.  Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Authors:  Paolo Sfriso; Sara Bindoli; Paola Galozzi
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

Review 4.  Adult-onset Still's disease.

Authors:  Valentina Bagnari; Matteo Colina; Giovanni Ciancio; Marcello Govoni; Francesco Trotta
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 3.580

Review 5.  Progress in Biological Therapies for Adult-Onset Still's Disease.

Authors:  Paola Galozzi; Sara Bindoli; Andrea Doria; Paolo Sfriso
Journal:  Biologics       Date:  2022-04-21

Review 6.  The potential utility of B cell-directed biologic therapy in autoimmune diseases.

Authors:  D G Arkfeld
Journal:  Rheumatol Int       Date:  2007-10-24       Impact factor: 2.631

7.  Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy.

Authors:  François Vercruysse; Thomas Barnetche; Estibaliz Lazaro; Emilie Shipley; François Lifermann; Alexandre Balageas; Xavier Delbrel; Bruno Fautrel; Christophe Richez; Thierry Schaeverbeke; Marie-Elise Truchetet
Journal:  Arthritis Res Ther       Date:  2019-02-12       Impact factor: 5.156

Review 8.  Adult-onset Still's disease: A disease at the crossroad of innate immunity and autoimmunity.

Authors:  Shijia Rao; Lemuel Shui-Lun Tsang; Ming Zhao; Wei Shi; Qianjin Lu
Journal:  Front Med (Lausanne)       Date:  2022-08-22

Review 9.  Life-threatening complications of adult-onset Still's disease.

Authors:  Petros Efthimiou; Sabeeda Kadavath; Bella Mehta
Journal:  Clin Rheumatol       Date:  2014-01-17       Impact factor: 2.980
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.